Over 1,800 physicians responded, providing valuable insight into how they are navigating the use of GLP-1 agonists
Inflammation, iron-deficiency anemia and unexplained weight gain may be other signs to watch for
The people who could benefit most from these medications are often those least able to afford them, perpetuating a cycle in which geography, income, and health outcomes remain tightly intertwined
Our comprehensive service includes unlimited support, ensuring you have access to answers and encouragement throughout your journey
Administer SEMGLEE subcutaneously into the abdominal area, thigh, or deltoid, and rotate injection sites within the same region from one injection to the next to reduce the risk of lipodystrophy and localized cutaneous amyloidosis